Fiona Stevens

Introduction to Angels in MedCity and Project Accelerate

Fiona Stevens and Peter Finnie will be speaking at the Introduction to Angels in MedCity and Project Accelerate event on Wednesday 11 July. The event, hosted by Oxford Academic Health Science Network and MedCity, will be an opportunity to discuss the funding initiatives, Project Accelerate and Angels in MedCity. Fiona...

Read more

Could the new EU Medical Devices Regulation put the UK MedTech industry in peril?

There has been much debate in recent years about the difficulty in attracting both private and public funds into the UK biotech industry.  At certain points, it seemed like a disproportionate percentage of the funding that was invested into UK biotech came from the US.  It is likely that there...

Read more

UK Supreme Court judgment in long-running dispute between Eli Lilly and Actavis on the combination therapy pemetrexed + vitamin B12 results in significant outcomes for patent infringement in the UK

In a judgment issued on 12 July, the UK Supreme Court made some significant changes in the law of UK patent infringement which could have far reaching consequences, especially in the pharmaceutical sector. In particular, they addressed the issue of infringement by equivalents not otherwise falling within the literal claim scope and...

Read more

The Importance of IP Due Diligence in M&A and Investment Transactions

Due diligence plays a central role in any M&A or investment transaction and its importance in guiding the transaction cannot be over stated. Fiona Stevens, a partner in GJE’s Life Sciences team who frequently advises on the intellectual property aspects of commercial transactions, discusses the importance of IP due diligence....

Read more